Mark S. Schroeder - 05 May 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: EVP, Pres Diagnostics & COO
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol: LH
Transactions as of: 05 May 2023
Net transactions value: $0
Form type: 4
Filing time: 09 May 2023, 16:45:39 UTC
Previous filing: 03 Apr 2023
Next filing: 22 May 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Non-qualified Stock Options	Award	$0	+1,400		$0.000000	1,400	05 May 2023	Common Stock	1,400	$223.86	Direct	F1, F2
transaction	LH	Restricted Stock Unit	Award	$0	+440	+16%	$0.000000	3,121	05 May 2023	Common Stock	440		Direct	F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F2	The option vests in three equal annual installments beginning on the date reflected in this column.
F3	Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F4	The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024.
F5	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.